glp-1 dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management - Beek - 2017 - Obesity Reviews Dumping syndrome: Causes, management, and

Mechanisms of amylin/leptin synergy in rodent models

While effective, the "cold chain" requirements and injection-based delivery remain significant barriers to global scale

Future research should prioritize long-term safety assessments, efficacy evaluations in specific populations, exploration of novel indications (eg, metabolic-associated fatty liver disease and obstructive sleep apnea), and mechanistic studies to enhance the therapeutic utility of these agents in metabolic and related diseases (See Figure 7)

Benefits of GLP-1 and GIP Medications These medications may help people with: Type 2 diabetes Overweight or obesity Heart or metabolic risk factors They may help the body: Produce more insulin when needed Lower blood sugar Feel full faster and longer Lose weight in some cases Types of GLP-1 Medications Single Agonists: These mimic only GLP-1 activity